In June 2011, the Food and Drug Administration issued a warning about the increased risk of bladder cancer associated with the diabetes medication Actos. In spite of the FDA’s warning linking Actos to bladder cancer, as of June 2012 the agency has not announced plans to recall the drug.
According to the FDA’s Actos warning, patients who used the diabetes drug for more than one year or who took the highest doses of the drug faced an increased risk of developing side effects. Researchers have found that long term Actos patients were 40% more likely to be diagnosed with bladder cancer than non-users; patients who received the highest doses of Actos faced a 75% increased bladder cancer risk.
The FDA’s warning about Actos advised patients to talk with their doctors if they experienced symptoms such as an increased need to urinate, pain during urination or blood in the urine, which could be signs of bladder cancer. Doctors were advised not to prescribe Actos to patients with active bladder cancer, and to use caution when prescribing the drug to patients with a history of the disease.
Although the FDA has declined to issue an Actos recall, health officials in other countries have already moved to restrict sales of the drug. After a French study uncovered a link between Actos and bladder cancer, health officials in France withdrew the drug from sale in that country. The study also prompted officials in Germany to halt sales of Actos to new patients.
If you or a loved one has taken Actos and were diagnosed with bladder cancer, you may be eligible to file a lawsuit. For a free legal consultation, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.